Dupont Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,567
| Closed | -$652K | – | 1776 |
|
|
2022
Q3 | $652K | Buy |
+9,567
| New | +$652K | 0.04% | 544 |
|
|
2020
Q4 | – | Sell |
-5,255
| Closed | -$290K | – | 1450 |
|
|
2020
Q3 | $290K | Sell |
5,255
-1,107
| -17% | -$61.1K | 0.01% | 989 |
|
|
2020
Q2 | $402K | Buy |
+6,362
| New | +$402K | 0.01% | 865 |
|
|
2020
Q1 | – | Sell |
-7,770
| Closed | -$618K | – | 1408 |
|
|
2019
Q4 | $618K | Hold |
7,770
| – | – | 0.01% | 739 |
|
|
2019
Q3 | $377K | Sell |
7,770
-833
| -10% | -$40.4K | 0.01% | 897 |
|
|
2019
Q2 | $453K | Hold |
8,603
| – | – | 0.01% | 832 |
|
|
2019
Q1 | $455K | Hold |
8,603
| – | – | 0.01% | 790 |
|
|
2018
Q4 | $353K | Buy |
8,603
+998
| +13% | +$41K | 0.01% | 850 |
|
|
2018
Q3 | $289K | Hold |
7,605
| – | – | 0.01% | 830 |
|
|
2018
Q2 | $344K | Sell |
7,605
-9,843
| -56% | -$445K | 0.01% | 795 |
|
|
2018
Q1 | $843K | Sell |
17,448
-683
| -4% | -$33K | 0.02% | 559 |
|
|
2017
Q4 | $713K | Buy |
+18,131
| New | +$713K | 0.02% | 582 |
|